User profiles for Arife Ulas
Arife UlasSBÜ Bursa Şehir uygulama ve araştırma hastanesi Verified email at sbu.edu.tr Cited by 873 |
[HTML][HTML] Bone metastasis from gastric cancer: the incidence, clinicopathological features, and influence on survival
Purpose To evaluate the incidence, clinicopathological characteristics, treatment outcomes,
prognostic factors, and survival of gastric cancer patients with bone metastases. Materials …
prognostic factors, and survival of gastric cancer patients with bone metastases. Materials …
[PDF][PDF] Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant …
Purpose: To investigate whether the pretreatment neutrophil lymphocyte ratio (NLR) and the
platelet lymphocyte ratio (PLR) have any prognostic significance in patients with HER2-…
platelet lymphocyte ratio (PLR) have any prognostic significance in patients with HER2-…
[HTML][HTML] A laboratory prognostic index model for patients with advanced non-small cell lung cancer
Purpose We aimed to establish a laboratory prognostic index (LPI) in advanced non-small
cell lung cancer (NSCLC) patients based on hematologic and biochemical parameters and to …
cell lung cancer (NSCLC) patients based on hematologic and biochemical parameters and to …
Medication errors in chemotherapy preparation and administration: a survey conducted among oncology nurses in Turkey
Background: Medication errors in oncology may cause severe clinical problems due to low
therapeutic indices and high toxicity of chemotherapeutic agents. We aimed to investigate …
therapeutic indices and high toxicity of chemotherapeutic agents. We aimed to investigate …
Risk factors for skeletal-related events (SREs) and factors affecting SRE-free survival for nonsmall cell lung cancer patients with bone metastases
A Ulas, A Bilici, A Durnali, S Tokluoglu, S Akinci… - Tumor Biology, 2016 - Springer
Skeletal-related events (SREs) for nonsmall cell lung cancer (NSCLC) patients with bone
metastasis lead to serious morbidity. The aim of this study was to determine risk factors for …
metastasis lead to serious morbidity. The aim of this study was to determine risk factors for …
Lapatinib plus capecitabine for HER2-positive advanced breast cancer: a multicentre study of Anatolian Society of Medical Oncology (ASMO)
Lapatinib is the first dual tyrosine kinase inhibitor of human epidermal growth factor receptor
type 2 (HER2/neu) and epidermal growth factor receptor (EGFR). The present study …
type 2 (HER2/neu) and epidermal growth factor receptor (EGFR). The present study …
[PDF][PDF] Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients …
Purpose: The impact of neoadjuvant chemotherapy (NACT) on immunohistochemical
markers in breast cancer specimens remains controversial. We designed the current study to …
markers in breast cancer specimens remains controversial. We designed the current study to …
Lung cancer in women, a different disease: survival differences by sex in Turkey
Purpose: In this study, we aimed to evaluate the effects of sex-based non-small cell lung
cancer (NSCLC) varieties on survival rates. Materials and Methods: A retrospective study was …
cancer (NSCLC) varieties on survival rates. Materials and Methods: A retrospective study was …
Oral etoposide for platinum-resistant and recurrent epithelial ovarian cancer: a study by the Anatolian Society of Medical Oncology
Background: The aim of this study was to evaluate the efficacy and toxicity of long-term, low-dose
oral etoposide as an advanced treatment option in patients with platinum resistant …
oral etoposide as an advanced treatment option in patients with platinum resistant …
Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumab
…, S Yuksel, M Inanc, O Bal, T Akman, D Yazilitas, A Ulas… - The Breast, 2016 - Elsevier
Purpose The aim of this study was to determine risk factors for brain metastasis as the first site
of disease recurrence in patients with HER2-positive early-stage breast cancer (EBC) who …
of disease recurrence in patients with HER2-positive early-stage breast cancer (EBC) who …